Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Myelodysplastic Syndromes 21Lymphoma, Non-Hodgkin 17Leukemia 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Lymphoma 9Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Hematologic Neoplasms 7Leukemia, Myeloid, Accelerated Phase 6Leukemia, Biphenotypic, Acute 6Congenital Abnormalities 6Blast Crisis 6Anemia, Refractory, with Excess of Blasts 6Multiple Myeloma 5Lymphoma, Large B-Cell, Diffuse 5Breast Neoplasms 5Neuroblastoma 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Juvenile 4Graft vs Host Disease 4Burkitt Lymphoma 4Recurrence 3Neuroectodermal Tumors, Primitive, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3

Interventions

Zoledronic Acid 1Thiotepa 1Surgical Procedures, Operative 1Stem Cell Transplantation 1Standard of Care 1Diphosphonates 1Denosumab 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplastic Cells, Circulating × Thiotepa × Clear all
NCT00429182 2013-04-10

Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
32 enrolled 6 charts
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡